← Back to Search

Standard of Care for Neurogenic Bladder (ConCaRe™ Trial)

N/A
Recruiting
Led By Diane Newman, D.N.P. F.A.A.N. B.C.B.-P.M.D.
Research Sponsored by Hollister Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

This observational research study aims to build a multinational electronic patient-reported outcomes (ePRO) registry of adult end users in outpatient and community settings using intermittent catheter(s) to void via the urethra to manage urinary retention and incomplete bladder emptying. Research participants will be asked to self-report on various attributes of their currently prescribed intermittent catheters and other various aspects of using an intermittent catheter.

Eligible Conditions
  • Neurogenic Bladder
  • Overactive Bladder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Creation of longitudinal continence care ePRO-based, direct-to-consumer registry
Secondary outcome measures
Identification of intermittent self-catheterization habits and behaviors

Trial Design

1Treatment groups
Experimental Treatment
Group I: Standard of CareExperimental Treatment1 Intervention
Individuals using an intermittent catheter to void urine through the urethra. Participants use their currently prescribed intermittent catheter per their clinician's standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Intermittent Catheter
2017
N/A
~40

Find a Location

Who is running the clinical trial?

Hollister IncorporatedLead Sponsor
13 Previous Clinical Trials
1,169 Total Patients Enrolled
ParexelIndustry Sponsor
308 Previous Clinical Trials
100,551 Total Patients Enrolled
Technomics ResearchIndustry Sponsor
3 Previous Clinical Trials
183 Total Patients Enrolled
~193 spots leftby May 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top